Loading insider details...
Latest Form 4 (Jan 6, 2026): Grant/Award of 234,000 JSPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 234,000 | n/a |
| Sep 24, 2025 | Jasper Therapeutics, Inc. (JSPR) | Purchase | 41,000 | $99.6K |
| Jun 6, 2025 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 234,000 | n/a |
| Feb 18, 2025 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 130,000 | n/a |
| Jun 12, 2024 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 10,000 | n/a |
| Feb 21, 2024 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 100,000 | n/a |
| Oct 13, 2023 | Jasper Therapeutics, Inc. (JSPR) | Tax Withholding | 87,531 | $74.4K |
| Apr 14, 2023 | Jasper Therapeutics, Inc. (JSPR) | Tax Withholding | 87,531 | $127.8K |
| Mar 20, 2023 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 500,000 | n/a |
| Feb 3, 2023 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 1,093,831 | n/a |